View abstract

Cet abstract a été assigné à session AOB Free Papers 2
Type de présentationOral presentation
TitreRuthenium Brachytherapy in Uveal Melanoma
ButReview of 136 uveal melanomas treated with ruthenium brachytherapy between 2019 and 2022. All tumors were treated with a top dosis of 100 Gy.
MéthodesOf 167 irradiations with ruthenium brachytherapy, 136 were applicated for uveal melanomas. We performed a retrospective analysis of the patients, the complications, local recurrence, and survival. In comparison with the literature available for ruthenium brachytherapy in uveal melanomas. On this moment three different radioactive plaques are available in UZLeuven for different tumor sizes and localisations.
RésultatsOf 136 uveal melanomas, there were 3 patients with persistent vitreal hemorrahges, 1 patient with persistent diplopia the first 4 months, 8 with (amplification of their) serous detachments. One patient developed an orbital recurrence. Five patients died of melanoma during the follow-up. Three patients were re-treated because of local recurrence.
ConclusionRuthenium brachytherapy is a good and safe procedure for treatment of uveal melanomas.
Conflit d'intérêtNon
Auteur 1
NomMISSOTTEN
InitialesG
InstitutUniversity Hospitals Leuven, Catholic University.
VilleLeuven
Auteur 2
NomChristiaens
InitialesM
InstitutUniversity Hospitals Leuven, Catholic University.
VilleLeuven
Auteur 3
NomClement
InitialesP
InstitutUniversity Hospitals Leuven, Catholic University
VilleLeuven
Auteur 4
NomVan Ginderdeuren
InitialesR
InstitutUniversity Hospitals Leuven, Catholic University
VilleLeuven
Auteur 5
NomVan Calster
InitialesJ
InstitutUniversity Hospitals Leuven, Leuven University
VilleLeuven
top ^